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Abstract
Background: The psychosocial development of pediatric HIV patients has not been extensively evaluated. The
study objectives were to evaluate whether emotional and social functions are differentially associated with HIV-
related complications.
Methods: A matched case-control study design was conducted. The case group (n = 20) consisted of vertically
infected children with HIV (aged 3-18 years) receiving HAART in Greece. Each case was matched with two randomly
selected healthy controls from a school-based population. CNS imaging and clinical findings were used to identify
patients with HIV-related neuroimaging abnormalities. The Wechsler Intelligence Scale III and Griffiths Mental Abilities
Scales were applied to assess cognitive abilities. The age specific Strengths and Difficulties Questionnaire was used to
evaluate emotional adjustment and social skills. The Fisher’s exact test, student’s t-test, and Wilcoxon rank sum test
were used to compare categorical, continuous, and ordinal scores, respectively, of the above scales between groups.
Results: HIV patients without neuroimaging abnormalities did not differ from patients with neuroimaging
abnormalities with respect to either age at HAART initiation (p = 0.306) or months of HAART treatment (p = 0.964).
While HIV patients without neuroimaging abnormalities had similar cognitive development with their healthy
peers, patients with neuroimaging abnormalities had lower mean General (p = 0.027) and Practical (p = 0.042)
Intelligence Quotient scores. HIV patients without neuroimaging abnormalities had an increased likelihood of both
Abnormal Emotional Symptoms (p = 0.047) and Hyperactivity scores (p = 0.0009). In contrast, HIV patients with
neuroimaging abnormalities had an increased likelihood of presenting with Abnormal Peer Problems (p = 0.033).
Conclusions: HIV patients without neuroimaging abnormalities are more likely to experience maladjustment with
respect to their emotional and activity spheres, while HIV patients with neuroimaging abnormalities are more likely
to present with compromised social skills. Due to the limited sample size and age distribution of the study
population, further studies should investigate the psychosocial development of pediatric HIV patients following the
disclosure of their condition.
Background
Untreated HIV infection among children has been asso-
ciated with childhood cognitive, motor, language, and
psychological developmental deficits [1,2]. Such develop-
mental deficits are attributed to central nervous system
disease involvement, including HIV-related neuroimaging
abnormalities. Mental and motor developmental delays
may commence at as early an age of 4 months, and may
present either as selective or global neurodevelopmental
delays [3]. Moreover, the consequent neuropsychological
deficits have been associated with the severity of HIV-
related neuroimaging abnormalities [4-7].
The introduction of novel antiretroviral therapies has
led to marked improvements regarding the survival and
consequent quality of life of HIV seropositive children
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ment of HIV through the administration of Highly
Active Antiretroviral Therapy (HAART) have dramati-
cally improved the disease prognosis among pediatric
patients. HAART has been associated with sustained
immune function and suppressed HIV viral load, as well
as the consequent diminishment of secondary infections
and malignancies, thus contributing to the prolonged
survival of patients [9,11,12].
As a result of the effectiveness of HAART manage-
ment, pediatric HIV patients have an enhanced survival,
albeit with a chronic condition, that may present with
related social, physical, and psychological challenges
affecting their development [12,13]. Thus, HIV pediatric
patients may have an elevated risk of presenting with
psychosocial problems, including conduct problems and
social maladjustment [3,7], similar to those observed
among other chronically ill pediatric patients [14,15]. It
i st h o u g h tt h a tb o t ht h ef r e q u e n c ya n ds e v e r i t yo fs u c h
problems may be most prominent among those children
with HIV-related complications, as observed among
patients with neuroimaging abnormalities [16,17].
The purposes of the present study are to evaluate the
psychosocial adjustment, including emotional and social
skills, of vertically infected HIV pediatric patients receiv-
ing HAART in Greece and to assess whether adverse
selective and/or global aspects of emotional and social
functions are differentially associated with HIV-related
complications, such as HIV-related neuroimaging
abnormalities.
Methods
Study design
A matched case-control study design was applied in
order to assess the study objectives. The study protocol
was approved by the Human Research and Ethics Com-
mittee of the ‘Aghia Sofia’ Children’s Hospital. Informed
consent for study participation was requested from all
participants’ legal guardians prior to study participation.
Study population
The source population of the case groups consisted of
all vertically infected children and adolescents with HIV
(n = 24) registered and monitored at the Hellenic
National Referral Centre for Pediatric HIV Infection. No
exclusion criteria for study participation regarding age,
gender, ethnicity, or socioeconomic status were applied.
Parental consent for study participation was not pro-
vided for one patient (4.1%). One patient (4.1%) died
during the course of the study and was thus excluded
from all further analyses. Two patients (8.3%) were
excluded since they were aged less than 6 months and,
consequently, an unreliable assessment of cognitive
and social skills was inherent. Hence, the response
rate among the remaining study population (n = 20)
was 100%.
Case groups
The case group consisted of 12 girls (60.0%) and 8 boys
(40.0%) aged between 3 through 18 years (mean age
11.76 ± 4.94 years). All study participants received
HAART. Upon study initiation, all members of the case
group underwent immunological and virological assess-
ments which indicated that the CD4 counts among par-
ticipants ranged between 394-1858 and 45% (n = 9) of
participants had an undetectable viral load. Members of
the case group were also subjected to a complete neuro-
logical examination and CNS imaging with CT and/or
MRI imaging. CNS imaging indicated that 25% (n = 5)
of HIV infected children had neuroimaging abnormal-
ities associated with HIV infection. HIV-related neuroi-
maging abnormalities were defined as brain imaging
findings relating to either symmetrical multiple hyperin-
tense signals localized bilaterally in the subcortical white
matter or micronodular multifocal calcifications distrib-
uted mainly in basal ganglia and cerebellum [7]. In addi-
tion, three out of five patients had movement disorders,
mainly spasticity of lower extremities. Hence, the follow-
ing case groups were established: (1) Case Group 1: HIV
infected children without neuroimaging abnormalities (n
= 15); and, (2) Case Group 2: HIV infected children
with neuroimaging abnormalities (n = 5).
Control group
The control group consisted of children and adolescents
selected from public primary and secondary schools
located in Athens, Greece. Eligible participants with a
history of speech, language, or communication impair-
ments, as well as other developmental disorders, were
excluded from the study. Two controls (n = 40) were
selected for each case, and were matched with respect
to gender, age (±1 year), and demographic variables,
including parental education (i.e. years of education)
and profession (i.e. manual, employee, and academic
professions).
Measurements
Assessment of Cognitive Development
All study participants underwent a detailed developmen-
tal assessment by experienced developmental pediatri-
cians at the Development Assessment Unit of the
“Aghia Sophia” Children’s Hospital in Athens, Greece.
Demographic characteristics and perinatal risk factors
known to influence cognitive development were assessed
retrospectively. Each child was assessed individually in a
secluded room, seated side by side with the develop-
mental paediatrician at a table suitable for the child’s
height. An identical order of assessments was imple-
mented for all study participants in order to diminish
the occurrence of an information bias consequent to
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aged less than 7 years was assessed with the Griffiths
Test, while those aged greater than 7 years was assessed
with the Greek standardized version of Wechsler Intelli-
gence Scale III (WISC III) [18-22]. Both tests were uti-
lized accordingly in order to derive General, Practical,
and Verbal Intelligence Quotient (IQ) levels, respec-
tively, for study participants. The following cut-off
values of IQ scores were applied for all cognitive func-
tions evaluated: (a) normal: 85 < IQ≤120; (b) mild: 70 <
IQ≤85; (c) moderate: 50 < IQ≤70; and (d) severe: IQ≤50.
Assessment of Psychosocial Adjustment
The age specific Strengths and Difficulties Questionnaire
(SDQ) was applied in order to evaluate study partici-
pants’ psychosocial adjustment, including emotional and
social skills. The SDQ is comprised of five components
including(1) Emotional Symptoms Score (Normal: 0-5;
Borderline: 6; Abnormal: 7-10); (2) Conduct Problems
S c o r e( N o r m a l :0 - 3 ;B o r d e r l i n e :4 ;A b n o r m a l :5 - 1 0 ) ;( 3 )
Hyperactivity Scale (Normal: 0-5; Borderline: 6; Abnor-
mal: 7-10); (4) Peer Problems Scale (Normal: 0-3; Bor-
derline: 4-5; Abnormal: 6-10); and (5) Prosocial Scale
(Normal: 6-10; Borderline: 5; Abnormal: 0-4). With the
exception of the Prosocial Scale, the sum of the scores
derived from the SDQ components was utilized in order
to generate the Total Difficulties Score (Normal: 0-15;
Borderline: 16-19; Abnormal: 20-40) of study partici-
pants [23-25]. The age specific SDQ questionnaire was
administered and completed by participants’ legal
guardians.
Statistical analysis
The predefined control group was applied as the basis of
comparison for all statistical analyses undertaken. The
student’s t-test was used to compare mean values of
continuous variables. Fisher’se x a c tt e s tw a su s e dt o
compare the occurrence of categorical variables, includ-
ing demographic characteristics and perinatal risk fac-
tors, between groups. Ordinal scores of both the IQ and
SDQ scales were compared with the Wilcoxon rank
sum exact test, respectively. A p-value (p)o f< 0 . 0 5w a s
considered as the significance criterion. Statistical ana-
lyses were conducted with SAS version 9.0 (SAS Insti-
tute Inc., USA).
Results
The study population (N = 60) consisted of twenty ver-
tically infected HIV positive children and forty controls
matched for age, gender, parental education, and paren-
tal profession. The mean age (± SD) of HIV patients
was 11.76 ± 4.94 years and did not significantly differ
from that of the control group (11.84 ± 4.80 years, p =
0.956). Among the case group (n = 20), 25% (n = 5) had
CNS imaging indicative of neuroimaging abnormalities
(Table 1). HIV patients without neuroimaging abnorm-
alities did not significantly differ from those with neu-
roimaging abnormalities with respect to age, treatment
regime, years of HAART treatment, and/or laboratory
findings, including viral load and CD4 cell counts
(Table 2).
Table 1 Demographic characteristics of the study population according to the presence of HIV-related neuroimaging
abnormalities (NA)
HIV patients without NA (n = 15) p-value HIV patients with NA (n = 5) p-value Control group (n = 40)
Age* 12.34 ± 4.58 0.721
† 10.00 ± 6.09 0.437
† 11.84 ± 4.80
Male gender 6 (40.0%) 0.242
‡ 2 (40.0%) 0.366
‡ 16 (40.0%)
Ethnicity
Greek 10 (66.7%) 1.00 4 (80.0%) 1.00 40 (100.0%)
Other 5 (33.3%) < 0.0001
‡ 1 (20.0%) 0.111
‡ 0 (0.0%)
Attendance in private school 0 (0.0%) 0.099
‡ 0 (0.0%) 0.485
‡ 9 (22.5%)
Mother’s Education* 8.40 ± 2.03 0.360
† 8.60 ± 4.83 0.711
† 9.15 ± 2.88
Father’s Education * 7.28 ± 2.03 0.106
† 9.60 ± 2.51 0.965
† 8.78 ± 2.41
Mother’s Profession 0.189
§ 0.526
§
Manual 15 (100.0%) 4 (80.0%) 34 (85.0%)
Employee 0 (0.0%) 0 (0.0%) 3 (7.5%)
Academic 0 (0.0%) 1 (20.0%) 3 (7.5%)
Father’s Profession 0,518
§ 0.237
§
Manual 12 (80.0%) 1 (20.0%) 25 (62.5%)
Employee 3 (20.0%) 4 (80.0%) 14 (35.0%)
Academic 0 (0.0%) 0 (0.0%) 1 (2.5%)
*Data expressed in mean years ± SD.
† Student’s t-test p-value.
‡ Fisher’s exact test p-value.
§ Likelihood ratio exact test.
Thomaidis et al. BMC Pediatrics 2010, 10:99
http://www.biomedcentral.com/1471-2431/10/99
Page 3 of 9HIV infected children without neuroimaging
abnormalities
As indicated in Table 1, 60.0% (n = 9) of HIV infected
children without neuroimaging abnormalities were girls.
HIV infected children without neuroimaging abnormal-
ities were not found to significantly differ from controls
with respect to either maternal or paternal educational
and/or professional levels (Table 1).
With regard to perinatal risk factors for impaired cog-
n i t i v ed e v e l o p m e n t ,o n l yas i n g l ec a s e( 6 . 7 % )o fH I V
infected children without neuroimaging abnormalities
was found to have been born prematurely. Moreover,
HIV infected children without neuroimaging abnormal-
ities were significantly more likely to have experienced
hypoxia at birth (Table 3).
With respect to the General IQ, while 40.0% (n = 6) of
patients without neuroimaging abnormalities were
observed to have scores indicative of moderate mental
retardation, none had severe mental retardation. In addi-
tion, 46.7% (n = 7) of this case group were observed to
have Practical IQ scores indicative of moderate retarda-
tion. Finally, with regard to the Verbal IQ, in excess of
one third of HIV infected children without neuroima-
ging abnormalities were found to have Verbal IQ scores
indicative of moderate retardation. Similarly to the Gen-
eral and Practical IQ scores, none of the HIV infected
children without neuroimaging abnormalities were
found to have IQ scores indicative of severe retardation
(Table 3).
With respect to the SDQ component scores, the over-
whelming majority of HIV infected children without
neuroimaging abnormalities were found to have normal
scores for all components of the SDQ (Table 4). How-
ever, HIV infected children without neuroimaging
abnormalities were significantly more likely to have both
Abnormal Emotional Symptoms and Hyperactivity
scores. Furthermore, none of the patients had abnormal
scores regarding their social behaviour (i.e. Peer Pro-
blems and Prosocial scores). Thus, HIV infected chil-
dren without neuroimaging abnormalities were observed
to experience maladjustment solely with respect to their
emotional and activity spheres, while their social skills
were unaffected (Table 4).
HIV infected children with neuroimaging abnormalities
As shown in Table 1, 40.0% (n = 2) of HIV infected
children with neuroimaging abnormalities were boys
and the majority (n = 4, 80.0%) were greater than
7 years of age. HIV infected children with neuroimaging
abnormalities were not found to significantly differ from
controls with respect to either maternal or paternal edu-
cational and/or professional levels (Table 1).
Eighty percent (n = 4) of HIV infected children with
neuroimaging abnormalities were born following the
Table 2 Comparison of patient characteristics according to the presence of HIV-related neuroimaging abnormalities
(NA)
HIV patients without NA (n = 15) HIV patients with NA (n = 5) p-value
Age* 12.35 ± 4.5 10 ± 6.0 0.371
†
HIV Treatment
HAART 9 (60.0%) 2 (40.0%) 0.298
‡
HAART + AZT 6 (40.0%) 3 (60.0%) -
Age of HAART Initiation* 6.59 ± 3.9 4.3 ± 5 0.306
†
Months on HAART * 5.75 ± 2.3 5.7 ± 2.5 0.964
†
Stage 0.026
§
A1 2 (13.3%) 0 (0.0%)
B1 or B2 or B3 13 (86.7%) 4 (80.0%)
C1 or C3 0 (0.0%) 1 (20.0%)
Viral Load 0.528
§
< 40 5 (33.3%) 1 (20.0%)
40-1000 8 (53.3%) 4 (80.0%)
1000-10 000 2 (13.3%) 0 (0.0%)
CD4 count 0.140
§
< 200 cells 1 (6.7%) 2 (40.0%)
200-500 cells 1 (6.7%) 0 (0.0%)
> 500 cells 13 (86.7%) 3 (60.0%)
*Data expressed in mean years ± SD.
† Student’s t-test p-value.
‡ Fisher’s exact test p-value.
§ Wilcoxon rank-sum test p-value.
Thomaidis et al. BMC Pediatrics 2010, 10:99
http://www.biomedcentral.com/1471-2431/10/99
Page 4 of 9conclusion of a full-term pregnancy and with normal
birth weight. However, HIV infected children with neu-
roimaging abnormalities were significantly more likely
than controls to have experienced hypoxia at birth
(Table 3).
In contrast to HIV infected children without neuroi-
maging abnormalities, none of those with neuroimaging
abnormalities presented with normal General, Practical,
or Verbal IQ scores. Among HIV patients with neuroi-
maging abnormalities, 40.0% (n = 2) had scores indica-
tive of moderate mental retardation regarding both the
General and Practical IQ scores. Moreover, in contrast
to those cases without neuroimaging abnormalities,
40.0% (n = 2) of HIV infected children with neuroima-
ging abnormalities had scores indicative of severe men-
tal retardation. Also, the majority of HIV infected
children with neuroimaging abnormalities (n = 3, 60.0%)
had Verbal IQ scores indicative of moderate retardation
and 20.0% (n = 1) had respective scores indicative of
severe mental retardation (Table 3).
None of the HIV infected children with neuroimaging
abnormalities were observed to have either Borderline
or Abnormal Total SDQ scores (Table 4). Moreover,
with regard to the SDQ component scores, all members
of the particular case group examined were observed to
have Normal Emotional Symptoms, Hyperactivity, and
Prosocial scores. These findings indicate that in contrast
to those cases without neuroimaging abnormalities, chil-
dren with HIV who presented with neuroimaging
abnormalities do not appear to have any grade of diffi-
culties regarding either their emotional and/or activity
spheres. However, HIV-patients with neuroimaging
abnormalities were significantly more likely than their
healthy peers to have Abnormal Peer Problems.
Discussion
Overall, the incidence of HIV infection in Greece (37.9
incident cases per million inhabitants) is markedly lower
than that reported in other Western European countries
(76.1 incident cases per million inhabitants) [15,26]. The
prevalence of HIV infection among pregnant women
residing in Greek urban areas (13 per 10,000 women) is
approximately half (1.32%) of that reported in other
European capitals [8,27]. Specifically, among 1517 preg-
nant women (1250 of Greek origin and 267 of other
ethnicities) surveyed during 1999-2000, 2 were HIV
p o s i t i v e .M o r e o v e r ,t h ec u m u l a t i v ep r e v a l e n c eo f
mother-to-child HIV transmissions (MTCT) in Greece
was 0.5% and is significantly lower than that reported
throughout the WHO European Region [6,10,27]. To
date, 24 children born with HIV MTCT currently reside
in Greece and are registered at the National Referral
Table 3 Perinatal risk factors and cognitive function according to the presence of HIV-related neuroimaging
abnormalities (NA)
HIV patients without NA (n = 15) p-value HIV patients with NA (n = 5) p-value Control group (n = 40)
Perinatal risk factors
Premature Birth 1 (6.7%) 0.434
† 1 (20.0%) 0.332
† 3 (7.5%)
Low Birth Weight 3 (20.0%) 0.205
† 1 (20.0%) 0.374
† 4 (10.0%)
Hypoxia at Birth 4 (26.7%) 0.004
† 3 (60.0%) < 0.0001
† 0 (0.0%)
Intelligence Quotient
General IQ Score* 82.4 ± 18.8 0.432
‡ 58.8 ± 11.82 0.027
‡ 78.0 ± 18.2
Normal (85 < IQ≤120) 6 (40.0%) 0 (0.0%) 10 (25.0%)
Mild (70 < IQ≤85) 3 (20.0%) 1 (20.0%) 16 (40.0%)
Moderate (50 < IQ≤70) 6 (40.0%) 2 (40.0%) 13 (32.5%)
Severe (IQ≤50) 0 (0.0%) 0.721
§ 2 (40.0%) 0.012
§ 1 (2.5%)
Practical IQ Score* 85.3 ± 22.6 0.306
‡ 57.6 ± 15.0 0.042
‡ 78.5 ± 21.6
Normal (85 < IQ≤120) 5 (33.3%) 0 (0.0%) 11 (27.5%)
Mild (70 < IQ≤85) 3 (20.0%) 2 (40.0%) 12 (30.0%)
Moderate (50 < IQ≤70) 7 (46.7%) 2 (40.0%) 16 (40.0%)
Severe (IQ≤50) 0 (0.0%) 0.975
§ 1 (20.0%) 0.108
§ 1 (2.5%)
Verbal IQ Score* 80.5 ± 14.9 0.660
‡ 65.6 ± 14.4 0.083
‡ 78.4 ± 15.3
Normal (85 < IQ≤120) 6 (40.0%) 0 (0.0%) 12 (30.0%)
Mild (70 < IQ≤85) 4 (30.8%) 1 (20.0%) 12 (30.0%)
Moderate (50 < IQ≤70) 5 (38.5%) 3 (60.0%) 14 (35.0%)
Severe (IQ≤50) 0 (0.0%) 0.848
§ 1 (20.0%) 0.066
§ 2 (5.0%)
* Data expressed as mean score ± SD.
† Fisher’s exact test p-value.
‡ Student’s t-test p-value.
§ Wilcoxon rank sum test exact p-value.
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(83.3%) were assessed for the purposes of the present
study. According to surveillance data compiled by the
Hellenic Centre of Infectious Diseases Control, MTCT
is the most frequent (63.76%) transmission route in chil-
dren aged less than 13 years. Hence, factors associated
with low prevalence rates of HIV infection among preg-
nant women in the specific region, including free access
to HIV screening tests during the first trimester of preg-
nancy and free access to antiretroviral drugs during
pregnancy, may have contributed to the low observed
levels of pediatric HIV infection in Greece [27,28].
The prevalence of HIV-related neuroimaging abnorm-
alities among vertically infected children with HIV eval-
uated for the purposes of our study was 25.0%. The
observed prevalence of neuroimaging abnormalities is
markedly greater than those reported in the scientific
literature, ranging between 1.6% and 10% [3,29]. Prior to
the introduction of HAART, the prevalence of neuroi-
maging abnormalities among HIV infected children ran-
ged between 35% and 50% [4]. The introduction of
HAART has contributed to the diminishment of such
findings [3]. The elevated prevalence of HIV-related
neuroimaging abnormalities among the study population
may be attributed to the fact that CNS involvement may
be the initial presentation of HIV infection among as
many as 18% of pediatric HIV patients [7].
With regard to the presence of perinatal risk factors
for impaired cognitive development, the study findings
indicated that HIV infected children both with and
without neuroimaging abnormalities were as likely as
controls to have experienced either premature birth
and/or low birth-weight. In contrast, both case groups
were more likely to have experienced hypoxia at birth as
compared to controls. Although the potential detrimen-
tal effects of hypoxia at birth upon consequent child-
hood development among otherwise healthy neonates
have been extensively documented, there exists limited
evidence regarding similar effects among neonates with
HIV infection [30].
The study findings indicated that only 40.0% of
patients without neuroimaging abnormalities had a gen-
eral IQ score within normal range. Moreover, none of
the patients without neuroimaging abnormalities had a
Table 4 Comparison of SDQ component scores according to the presence of HIV-related neuroimaging abnormalities
(NA)
SDQ
Component Score
HIV patients without NA (n = 15) p-value HIV patients with NA
(n = 5)
p-value Control group (n = 40)
Emotional Mean ± SD* 3.4 ± 2.3 0.073
† 2.2 ± 1.1 0.822
† 2.4 ± 1.7
Normal 12 (80.0%) 5 (100.0%) 38 (95.0%)
Borderline 1 (6.7%) 0 (0.0%) 2 (5.0%)
Abnormal 2 (13.3%) 0.047
‡ 0 (0.0%) 0.788
‡ 0 (0.0%)
Conduct Mean ± SD* 1.7 ± 1.5 0.533
† 2.6 ± 0.9 0.255
† 2.0 ± 1.2
Normal 13 (86.7%) 4 (80.0%) 35 (87.5%)
Borderline 1 (6.7%) 1 (20.0%) 4 (10.0%)
Abnormal 1 (6.7%) 0.838
‡ 0 (0.0%) 0.529
‡ 1 (2.5%)
Hyperactivity Mean ± SD* 4.3 ± 2.9 0.071
† 2.6 ± 1.7 0.503
† 3.1 ± 1.6
Normal 10 (66.7%) 5 (100.0%) 38 (95.0%)
Borderline 2 (13.3%) 0 (0.0%) 1 (2.5%)
Abnormal 3 (20.0%) 0.009
‡ 0 (0.0%) 0.788
‡ 1 (2.5%)
Peer Problems Mean ± SD* 2.5 ± 1.6 0.600
† 2.2 ± 2.4 0.941
† 2.2 ± 1.3
Normal 14 (93.3%) 4 (80.0%) 38 (95.0%)
Borderline 1 (6.7%) 0 (0.0%) 2 (5.0%)
Abnormal 0 (0.0%) 0.587
‡ 1 (20.0%) 0.033
‡ 0 (0.0%)
Prosocial Mean ± SD* 8.5 ± 1.6 0.630
† 8.6 ± 1.9 0.699
† 8.3 ± 1.6
Normal 14 (93.3%) 5 (100.0%) 36 (90.0%)
Borderline 1 (6.7%) 0 (0.0%) 3 (7.5%)
Abnormal 0 (0.0%) 0.921
‡ 0 (0.0%) 0.613
‡ 1 (2.5%)
Total Score Mean ± SD* 11.7 ± 6.6 0.120
† 9.6 ± 2.6 0.769
† 9.1 ± 3.6
Normal 11 (73.3%) 5 (100.0%) 39 (97.5%)
Borderline 1 (6.7%) 0 (0.0%) 1 (2.5%)
Abnormal 3 (20.0%) 0.007
‡ 0 (0.0%) 0 (0.0%)
* Data expressed as mean score ± SD.
† Student’s t-test p-value.
‡ Wilcoxon rank sum test exact p-value.
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No statistically significant difference was observed
between the Verbal and the Practical IQ scores of HIV
patients without neuroimaging abnormalities as com-
pared to their healthy peers. Hence, vertically infected
children without neuroimaging abnormalities receiving
HAART were observed to have a global intelligence ana-
logous to non-infected children. The study findings are
in agreement with those established in the literature
[30-32]. Elevated rates of moderate and severe cognitive
impairment among children with HIV have been
reported [8,10] but are attributed to the lack or limited
administration of HAART among the children examined
[4,32].
Due to the structural, and consequent functional,
alterations inherent in the central nervous system, the
effects of HIV-related CNS involvement upon children’s
cognitive development have been documented [4,6,7]. In
the present study, among children with HIV and conco-
mitant neuroimaging abnormalities, none had a General,
Practical, and/or Verbal IQ score within the normal
range. Moreover, two fifths of the patients in this group
had a General IQ score indicative of severe mental
retardation. Thus, despite the administration of
HAART, children with HIV who presented with neuroi-
maging abnormalities were observed to have severe defi-
cits in cognitive function as compared to non-infected
children.
With respect to the emotional and social skills of HIV
infected children, neither those children with nor with-
out neuroimaging abnormalities had SDQ scores indica-
tive of abnormal overall psychosocial maladjustment.
This is in agreement with similar findings in the litera-
ture [33,34]. Moreover, patients without neuroimaging
abnormalities were significantly more likely to have
abnormal Emotional and Hyperactivity scores as com-
pared to their healthy peers. Even so, among patients
without neuroimaging abnormalities, neither their emo-
tional nor their social skills were affected. These find-
ings, though, may be partly attributed to the fact that
patients had not been disclosed of their specific health
condition prior to the time of assessment.
In contrast, children with HIV who presented with
neuroimaging abnormalities had an elevated frequency
of Abnormal Peer Problems, as compared to their
healthy counterparts. However, while the social skills of
patients with neuroimaging abnormalities were compro-
mised, their emotional adjustment was similar to that of
their healthy peers. The impaired verbal skills of chil-
dren with HIV who presented with neuroimaging
abnormalities may lead to compromised communication
skills and consequent impaired peer relations [34]. As a
result, such impaired functions may be attributed multi-
laterally to both impaired cognitive and verbal skills.
This study provides evidence suggesting that vertically
infected children with HIV receiving HAART are
observed to have an increased risk for poor cognitive
outcome solely if they present with HIV-related neuroi-
maging abnormalities. As compared to their healthy
peers, pediatric patients without neuroimaging abnorm-
alities are more likely to experience maladjustment with
respect to their emotional and activity spheres, while
children with HIV who present with neuroimaging
abnormalities are more likely to have compromised
social skills. The observed normal scores regarding emo-
tional adjustment and social parameters could be attrib-
uted either to the fact that systematic psychological and
social support is provided by the national health ser-
vices, or to the fact that all cognitive, emotional, and
social skills assessments took place prior to the disclo-
sure of HIV infection among the population examined.
Children who are unable to master adaptive strategies
for emotional self-regulation at early ages demonstrate
numerous problematic outcomes, including impaired
social competence and delayed externalization of pro-
blems during late adulthood [35-37]. The present study
findings indicating that pediatric HIV patients have an
increased likelihood of abnormal emotional and hyper-
activity scores may be indicative of a potentially elevated
risk for impaired social skills in adulthood, particularly
following the additional emotional distress inherently
imposed following the disclosure of patients’ disease sta-
tus. As a result, it is recommended that the assessment
of both the emotional and social skills of pediatric HIV
patients should be undertaken prior to disclosure in
order to efficaciously address the further development
of either emotional and/or social maladjustment [38].
The strengths of the study include its contribution to
the related scientific literature regarding the concomi-
tant assessment of cognitive, emotional, and social func-
tion among children with HIV according to the
occurrence of HIV-related neuroimaging abnormalities,
following HAART. Moreover, while the study popula-
tion reflects in excess of 83% of all pediatric HIV
patients reported in Greece, its limited size may inhibit
the generalization of the study findings to larger cohorts,
particularly of older age. Due to the cross-sectional
study design, the limitations of the study include the
inability to establish an etiological relationship between
HIV-related neuroimaging abnormalities and impaired
cognitive and psychosocial development among pediatric
HIV patients receiving HAART. A longitudinal study is
necessary in order to assess whether the emotional and
psychosocial characteristics of pediatric HIV patients in
adulthood may vary, independently of HIV-related neu-
roimaging abnormalities, following the disclosure of
their condition, initiation of sexual relationships, and
consequent lifestyle changes.
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HIV infected children without neuroimaging abnormal-
ities are more likely to experience maladjustment with
respect to their emotional and activity spheres, while
HIV infected children with neuroimaging abnormalities
are more likely to present with compromised social
skills. Optimal emotional adjustment and social para-
meters may be attained by systematic psychological and
social support provided by the national health services.
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